Target intelligence / Profile preview

Amyloid Pore

Molecular classification
Pore-forming protein, Oligomeric protein assembly, Ion channel (non-selective)
01

Overview

Amyloid pores are membrane-spanning structures formed by the oligomerization of amyloidogenic peptides, primarily amyloid-β (Aβ). These pores disrupt cellular ion homeostasis, particularly calcium, and are implicated in neurotoxicity in Alzheimer's disease. They are typically composed of small Aβ oligomers assembled into β-barrel-like structures that insert into lipid bilayers, acting as non-selective cation channels. Targeting these pores represents a therapeutic strategy for AD.

Other names
Aβ poreAmyloid-beta poreAmyloid channelAβ oligomeric poreAmyloid beta pore-forming oligomer
02

Mechanism of action

Inhibition of amyloid pore formation; Stabilization of amyloid-beta monomers/oligomers to prevent pore formation; Blockage of ion channel activity of amyloid pores

03

Biological functions

Membrane permeabilizationIon channel activityCalcium dysregulationInduction of cell deathDisruption of neuronal homeostasis
04

Disease associations

Alzheimer's diseaseNeurodegenerative diseaseAmyloidosis
05

Safety considerations

Off-target effects on other membrane proteinsPotential for immune response against therapeutic agents targeting AβDelivery of therapeutic agents across the blood-brain barrier
06

Biomarkers

Aβ oligomer levels in cerebrospinal fluidAβ oligomer levels in plasmaPET imaging of Aβ oligomersCalcium dysregulation in neurons

Beyond the preview

Go deeper on Amyloid Pore.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Amyloid Pore.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call